Company intelligence / Profile preview

Jinzhou Bioling

Jinzhou, Liaoning, China

Ownership: Private
Development stage: Other

Overview

Jinzhou Bioling Pharmaceutical is a Chinese pharmaceutical company specializing in the development, manufacture, and sale of finished dosage forms and active pharmaceutical ingredients (APIs). The company focuses primarily on anti-infective agents, including a wide range of antibiotics such as cephalosporins, macrolides, and quinolones. Operating out of Jinzhou, Liaoning Province, the firm maintains GMP-certified production facilities for tablets, capsules, and granules. Their product portfolio serves the domestic Chinese market with essential medicines for respiratory, urinary, and gastrointestinal infections.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jinzhou Bioling.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinzhou Bioling.

Explore the full profile